Conavi Medical Corp (CNVI.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 09-2024 | |
| Cash Flows From Operating Activities | |
| Depreciation Amortization | 240 |
| Accounts receivable | -231 |
| Other Working Capital | 1,553 |
| Other Operating Activity | -6,026 |
| Operating Cash Flow | $-4,464 |
| Cash Flows From Investing Activities | |
| PPE Investments | -159 |
| Purchase Sale Intangibles | -47 |
| Investing Cash Flow | $-206 |
| Cash Flows From Financing Activities | |
| Change In Short Term Borrowing | 3,530 |
| Debt Repayment | -170 |
| Financing Cash Flow | $3,360 |
| Beginning Cash Position | 1,746 |
| End Cash Position | 436 |
| Net Cash Flow | $-1,310 |
| Free Cash Flow | |
| Operating Cash Flow | -4,464 |
| Capital Expenditure | -206 |
| Free Cash Flow | -4,670 |